Camingaw, Mary Jane O.

HRN: 22-25-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
CEFUROXIME 500MG (TAB)
11/27/2022
12/04/2022
PO
500mg
BID
Thickly MSAF
Waiting Final Action 
11/27/2022
METRONIDAZOLE 500MG (TAB)
11/27/2022
12/04/2022
PO
500mg
Q8
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: